Skip to main content
Top
Published in: Journal of Genetic Counseling 2/2017

01-04-2017 | Case Study

Disclosing Huntington’s Genetic Testing Results in the Context of Intellectual Disability and Guardianship: Using the Family Illness Narrative to Guide the Flow of Information

Authors: Mark B. Warren, Kathryn M. Schak

Published in: Journal of Genetic Counseling | Issue 2/2017

Login to get access

Abstract

A diagnosis of Huntington’s disease has broad social, vocational, reproductive and psychological implications. The ability to accurately diagnose the illness via genetic testing is not new. However, given a persistent lack of robustly effective interventions, it remains an area of ethical concern. The difficulty is compounded in cases of intellectual disability. This paper presents a case of genetic testing for Huntington’s disease conducted on a patient with intellectual disability with guardian consent, but without the patient’s direct knowledge and how the family illness narrative and psychiatric care were employed in the eventual disclosure of the patient’s diagnosis and subsequent management.
Literature
go back to reference Ahmed T, Raza SH, Maryam A, Setzer W, Braidy N, Nabavi SF, et al. (2016, Epub ahead of print). Ginsenoside Rb1 as neuroprotective agent: a review. Brain Research Bulletin. Ahmed T, Raza SH, Maryam A, Setzer W, Braidy N, Nabavi SF, et al. (2016, Epub ahead of print). Ginsenoside Rb1 as neuroprotective agent: a review. Brain Research Bulletin.
go back to reference Committee on Bioethics, Committee on Genetics, and, The American College of Medical Genetics and, Genomics Social, Ethical, and Legal Issues Committee (2013). Ethical and Policy Issues in Genetic Testing and Screening of Children. Pediatrics, 131, 620–622.CrossRef Committee on Bioethics, Committee on Genetics, and, The American College of Medical Genetics and, Genomics Social, Ethical, and Legal Issues Committee (2013). Ethical and Policy Issues in Genetic Testing and Screening of Children. Pediatrics, 131, 620–622.CrossRef
go back to reference Dobson, L., Träger, U., Farmer, R., Hayardeny, L., Loupe, P., Hayden, M. R., et al. (2016). Laquinimod dampens hyperactive cytokine production in Huntington’s disease patient myeloid cells. Journal of Neurochemistry, 137, 782–794.CrossRefPubMedPubMedCentral Dobson, L., Träger, U., Farmer, R., Hayardeny, L., Loupe, P., Hayden, M. R., et al. (2016). Laquinimod dampens hyperactive cytokine production in Huntington’s disease patient myeloid cells. Journal of Neurochemistry, 137, 782–794.CrossRefPubMedPubMedCentral
go back to reference Jia, H., Wang, Y., Morris, C. D., Jacques, V., Gottesfeld, J. M., Rusche, J. R., et al. (2016). The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington’s disease mice. PloS One, 11, e0152498.CrossRefPubMedPubMedCentral Jia, H., Wang, Y., Morris, C. D., Jacques, V., Gottesfeld, J. M., Rusche, J. R., et al. (2016). The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington’s disease mice. PloS One, 11, e0152498.CrossRefPubMedPubMedCentral
go back to reference Killoran, A., & Biglan, K. M. (2014). Current therapeutic options for Huntington’s disease: good clinical practice versus evidence-based approaches? Movement Disorders, 29, 1404–1413.CrossRefPubMed Killoran, A., & Biglan, K. M. (2014). Current therapeutic options for Huntington’s disease: good clinical practice versus evidence-based approaches? Movement Disorders, 29, 1404–1413.CrossRefPubMed
go back to reference Rhodes, R. (2006). Why test children for adult-onset genetic diseases? Mount Sinai Journal of Medicine, 73, 609–616.PubMed Rhodes, R. (2006). Why test children for adult-onset genetic diseases? Mount Sinai Journal of Medicine, 73, 609–616.PubMed
go back to reference Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245.CrossRefPubMed Ross, L. F., Saal, H. M., David, K. L., & Anderson, R. R. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15, 234–245.CrossRefPubMed
go back to reference Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed
go back to reference Scully, J. L., Porz, R., & Rehmann-Sutter, C. (2007). You don’t make genetic test decisions from one day to the next’--using time to preserve moral space. Bioethics, 21, 208–217.CrossRefPubMed Scully, J. L., Porz, R., & Rehmann-Sutter, C. (2007). You don’t make genetic test decisions from one day to the next’--using time to preserve moral space. Bioethics, 21, 208–217.CrossRefPubMed
go back to reference The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.CrossRef The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.CrossRef
go back to reference Werner-Lin, A., & Gardner, D. S. (2009). Family illness narratives of inherited cancer risk: continuity and transformation. Families, Systems and Health, 27, 201–212.CrossRefPubMed Werner-Lin, A., & Gardner, D. S. (2009). Family illness narratives of inherited cancer risk: continuity and transformation. Families, Systems and Health, 27, 201–212.CrossRefPubMed
Metadata
Title
Disclosing Huntington’s Genetic Testing Results in the Context of Intellectual Disability and Guardianship: Using the Family Illness Narrative to Guide the Flow of Information
Authors
Mark B. Warren
Kathryn M. Schak
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 2/2017
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-016-0007-1

Other articles of this Issue 2/2017

Journal of Genetic Counseling 2/2017 Go to the issue